Ligand Pharmaceuticals Inc

Ownership Transactions Reported by 17 Insiders

Symbol
LGND on Nasdaq, LGNDZ, LGNXZ, LGNYZ, LGNZZ on OTC
Location
3911 Sorrento Valley Blvd, Suite 110, San Diego, California

Insiders trading volume in the past year

Ligand Pharmaceuticals Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
John L. Higgins Director $30.2M Dec 28, 2022
Matthew W. Foehr Former Executive Officer $11.7M Nov 1, 2022
Todd C. Davis Chief Executive Officer, Director $7.95M +$238K +3.08% Mar 25, 2024
Matthew E. Korenberg President & Chief Operating $7.39M -$1.5M -16.8% May 13, 2024
Jason Aryeh Director $6.98M Apr 30, 2024
Stephen L. Sabba Director $2.15M -$141K -6.14% Mar 5, 2024
Sunil Patel Former Director $2.08M Nov 1, 2022
John L. Lamattina Director $2.04M Jun 9, 2023
Octavio Espinoza Chief Financial Officer $2.03M -$1.16M -36.4% May 15, 2024
Andrew Reardon Chief Legal Officer & $1.84M -$830K -31.1% May 9, 2024
Charles S. Berkman Former Executive Officer $1.72M Nov 1, 2022
John W. Kozarich Director $1.67M Apr 24, 2024
Nancy Ryan Gray Director $469K -$77.7K -14.2% May 9, 2024
Jason Haas Director $300K Jun 9, 2023
Sarah Boyce Former Director $209K Nov 1, 2022
Martine Zimmermann Director $165K Sep 22, 2023
Jennifer R. Cochran Former Director $84K Nov 1, 2022

Recent Insider Transactions by Companies or Individuals for Ligand Pharmaceuticals Inc

Insider Class Transaction % Value $ Price $ Shares Shares Owned Date Ownership